Myovant Sciences Ltd (MYOV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MYOV | MLTX | ADMA | ||
| Company | Myovant Sciences Ltd | Moonlake Immunotherapeutics | Adma Biologics | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 26.99 | 41.67 | 11.20 | ||
| High | 27.00 | 42.21 | 11.47 | ||
| Low | 26.98 | 41.03 | 11.01 | ||
| Last | 26.98 | 42.03 | 11.46 | ||
| Change | -0.01 | -0.17 | +0.25 | ||
| % Change | -0.04% | -0.40% | +2.23% | ||
| Volume | 2,256,000 | 270,800 | 2,025,900 | ||
| 20-Day Average Volume | 1,234,240 | 344,240 | 3,089,325 | ||
| Previous Close | 26.99 | 42.20 | 11.21 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 26.95 | 41.25 | 10.88 | ||
| 20-Day Raw Stochastic | 50.00% | 54.57% | 86.29% | ||
| 20-Day Relative Strength | 61.08% | 50.84% | 73.43% | ||
| Weighted Alpha | +96.20 | -15.89 | +237.38 | ||
| Today's Opinion | 100% Buy | 64% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 64% Sell | 100% Buy | ||
| Last Month's Opinion | 96% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.11% since 03/02/23 | +0.82% since 06/27/24 | +4.66% since 06/27/24 | ||
| Low | 26.95 on 03/06/23 | 39.91 on 07/03/24 | 10.93 on 06/28/24 | ||
| High | 27.00 on 03/09/23 | 45.76 on 07/01/24 | 11.68 on 07/02/24 | ||
| 1-Month | |||||
| %Chg | +0.30% since 02/09/23 | -2.05% since 06/05/24 | +9.25% since 06/05/24 | ||
| Low | 26.90 on 02/13/23 | 37.55 on 06/24/24 | 10.07 on 06/10/24 | ||
| High | 27.06 on 02/13/23 | 45.76 on 07/01/24 | 11.68 on 07/02/24 | ||
| 3-Month | |||||
| %Chg | +0.71% since 12/09/22 | -10.90% since 04/05/24 | +79.34% since 04/05/24 | ||
| Low | 26.75 on 12/16/22 | 37.55 on 06/24/24 | 5.89 on 04/10/24 | ||
| High | 27.06 on 02/13/23 | 47.72 on 04/08/24 | 11.68 on 07/02/24 | ||
| 6-Month | |||||
| %Chg | +36.13% since 09/09/22 | -23.13% since 01/05/24 | +160.45% since 01/05/24 | ||
| Low | 16.26 on 09/23/22 | 37.55 on 06/24/24 | 4.61 on 01/08/24 | ||
| High | 27.06 on 02/13/23 | 64.98 on 02/12/24 | 11.68 on 07/02/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,623,400 | 2,696,032 | 2,598,579 | ||
| Shares Outstanding, K | 97,235 | 63,887 | 231,809 | ||
| Annual Sales | 230,970,000 | 0 | 258,220,000 | ||
| Annual Net Income | -205,980,000 | -36,010,000 | -28,240,000 | ||
| Last Quarter Sales | 100,230,000 | 0 | 81,880,000 | ||
| Last Quarter Net Income | -57,630,000 | -13,670,000 | 17,810,000 | ||
| 60-Month Beta | 2.17 | 1.25 | 0.55 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.59 on 01/26/23 | -0.22 on 05/07/24 | 0.08 on 05/09/24 | ||
| Latest Earnings Date | 01/25/23 | 08/08/24 | 08/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 103.64 | ||